2 employees
DepYmed is a disease therapeutic development company that develops potent inhibitors of the enzyme PTP1B.
2014
$2M
from 2 investors over 2 rounds
DepYmed, Inc. raised $2M on December 18, 2017
Investors: Accelerate NY Seed Fund
DepYmed, Inc. raised $100K on December 22, 2015
Investors: Accelerate Long Island